Allergy and Asthma Proceedings· 2026Q2
Chronic autoimmune urticaria with worsening during the luteal phase suggestive of progesterone hypersensitivity successfully treated with rituximab
- 1citations
- Q2SCImago
- 2026year
Short summary
Rituximab successfully treated a 30-year-old woman's chronic autoimmune urticaria (CAU) that worsened during her luteal phase, suggesting progesterone hypersensitivity, allowing her to taper off glucocorticoids and tolerate progesterone without hives.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Rheumatology
RheumatologyMedicine